logo
    • Magazine
    • Membership
    • Donate
  • Racial Justice
  • Economic Justice
    • Collections
  • Climate Justice
  • Health Justice
  • Leadership
  • CONTENT TYPES
  • Subscribe
  • Webinars
    • Upcoming Webinars
    • Complimentary Webinars
    • Premium On-Demand Webinars
  • Membership
  • Submissions

Another Pharma Charity Kickback Scheme Settled: Price Tag $360 Million

Ruth McCambridge
December 7, 2018
Share
Tweet
Share
Email
Print
Creative Commons Zero – CC0.

December 6, 2018; Reuters

Want to know more about how the charity sector is complicit in soaring drug prices?

Yesterday, the Justice Department announced the largest settlement to date in a kickback scheme between a pharmaceutical company and a so-called patient charity operation, the Caring Voice Coalition (CVC). NPQ covered that organization’s own problems with the federal government last year when its license to provide patient aid was revoked due to the closeness and influence drug companies had over the operation. In this case, Actelion Pharmaceuticals, which is now under the umbrella of Johnson & Johnson, will pay the US government $360 million to settle its case in which it was accused of improperly paying the co-pay obligations of thousands of Medicare patients using its own hypertension drugs—Tracleer, Ventavis, Veletri, and Opsumit. This self-serving behavior, aimed apparently at driving up drug prices while creating a strong market, is deemed a misuse of charity and is prohibited. The Justice Department has been energetic in filing legal suits against the pharmaceutical companies engaged in such behavior.

Sign up for our free newsletters

Subscribe to NPQ's newsletters to have our top stories delivered directly to your inbox.

By signing up, you agree to our privacy policy and terms of use, and to receive messages from NPQ and our partners.

CVC stopped providing aid after the government revoked its approval to do so in 2017 because of concerns drug-makers had improper influence over it. This is the second time it has figured in one of these cases; the previous case, resolved for $210 million in 2017, was against United Therapeutics Corp. for improperly using the charity to cover co-payments. In May, Pfizer settled a similar suit involving a different charity for nearly $23.85 million. Likewise, Jazz Pharmaceuticals and Lundbeck settled similar cases for $57 million and $52.6 million, respectively.

In what has become a standard pattern, Actelion was accused of obtaining data from CVC that detailed the degree to which patients used its drugs, then using the information to budget for future payments. This encouraged the charity to boost the drugs provided by the donor company. It’s a neat little business plan…if you don’t get caught.—Ruth McCambridge

Share
Tweet
Share
Email
Print
About the author
Ruth McCambridge

Ruth is Editor Emerita of the Nonprofit Quarterly. Her background includes forty-five years of experience in nonprofits, primarily in organizations that mix grassroots community work with policy change. Beginning in the mid-1980s, Ruth spent a decade at the Boston Foundation, developing and implementing capacity building programs and advocating for grantmaking attention to constituent involvement.

More about: AccountabilityBig Pharmadrug manufacturersNonprofit Newspatient advocacyPhilanthropy

Become a member

Support independent journalism and knowledge creation for civil society. Become a member of Nonprofit Quarterly.

Members receive unlimited access to our archived and upcoming digital content. NPQ is the leading journal in the nonprofit sector written by social change experts. Gain access to our exclusive library of online courses led by thought leaders and educators providing contextualized information to help nonprofit practitioners make sense of changing conditions and improve infra-structure in their organizations.

Join Today
logo logo logo logo logo
See comments

Spring-2023-sidebar-subscribe
You might also like
Arab American Philanthropy
Tamara El-Khoury
The Nonprofit Sector and Social Change: A Conversation between Cyndi Suarez and Claire Dunning
Claire Dunning and Cyndi Suarez
Nonprofits as Battlegrounds for Democracy
Cyndi Suarez
Sankofa Philanthropy: Hip Hop’s Sixth Element
Jason Terrell
Why Social Change Films Matter
Cyndi Suarez and Saphia Suarez
Philanthropy Must Move from Charity to Solidarity
Son Chau

NPQ Webinars

April 27th, 2 pm ET

Liberatory Decision-Making

How to Facilitate and Engage in Healthy Decision-making Processes

Register Now
You might also like
Brown-skinned Arabic woman wearing a bowler hat and looking into the camera. She is standing in front of a bougainvillea plant.
Arab American Philanthropy
Tamara El-Khoury
The book "Nonprofit Neighborhoods" leaning against a wall
The Nonprofit Sector and Social Change: A Conversation...
Claire Dunning and Cyndi Suarez
Nonprofits as Battlegrounds for Democracy
Cyndi Suarez

Like what you see?

Subscribe to the NPQ newsletter to have our top stories delivered directly to your inbox.

See our newsletters

By signing up, you agree to our privacy policy and terms of use, and to receive messages from NPQ and our partners.

NPQ-Spring-2023-cover

Independent & in your mailbox.

Subscribe today and get a full year of NPQ for just $59.

subscribe
  • About
  • Contact
  • Advertise
  • Copyright
  • Careers

We are using cookies to give you the best experience on our website.

 

Non Profit News | Nonprofit Quarterly
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.